Announcements
Projects
Orgs
Project
Articles 2
Votes 0
Bms.com

Authors 1

Bristol-Myers Squibb
SystImmune and Bristol Myers Squibb Announce a Global Strategic Collaboration Agreement for the Development and Commercialization of BL-B01D1 - Bristol-Myers Squibb
~2y
Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy Shows Overall Survival and Progression-Free Survival Benefit for Cisplatin-Eligible Patients with Unresectable or Metastatic Urothelial Carcinoma in the Phase 3 CheckMate -901 Trial - Bristol-Myers Squibb
>2y